| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $682.2M | -30.7% |
| Cost of Revenue | $202.7M | -41.0% |
| R&D Expense | $391.2M | -47.0% |
| SG&A Expense | $337.2M | -28.1% |
| Operating Income | -$248.9M | +56.1% |
| Interest Expense | $10.4M | -27.6% |
| Pre-tax Income | -$176.6M | +67.5% |
| Income Tax | $10.9M | +435.9% |
| Net Income | -$187.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $530.2M | -6.7% |
| Short-term Investments | $392.9M | — |
| Inventory | $8.7M | -79.0% |
| Current Assets | $1.13B | -1.3% |
| Total Assets | $1.56B | -13.2% |
| Current Liabilities | $1.15B | -29.4% |
| Total Liabilities | $2.18B | -13.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$87.3M | +87.8% |
| Capital Expenditures | $13.1M | -75.7% |
| Investing Cash Flow | -$204.0M | -247.0% |
| Financing Cash Flow | $260.6M | +5734.8% |
| Free Cash Flow | -$100.3M | +86.9% |
| +65.6% |
| EPS (Basic) | -$1.23 | +77.3% |
| EPS (Diluted) | -$1.23 | +77.3% |
| Stockholders' Equity |
| -$623.8M |
| +13.0% |